Two new GDP Non-Compliance Reports Published in June 2022
Recommendation

22 October 2026
Good Distribution Practice of Active Substances for Human and Veterinary Medicinal Products
In June 2022, two new GPD Non-Compliance Reports were entered into the EudraGMPD Database.
In both cases, it was found during an inspection that the companies concerned did not comply with the GDP requirements referred to in Article 84 of Directive 2001/83/EC. As a consequence, the wholesale authorisations were suspended.
German Wholesale Distributor
The first GPD Non-Compliance Report, dated 01 June 2022, comes from the competent authority of German (Department of Occupational Health and Safety, Customer Protection and Health). During an inspection at a wholesale distributor from Cottbus, Brandenburg, the following deficiencies were found:
- No access to pharmaceutical Quality System
- No responsible person for Wholesale Distribution
Source: EudraGMDP Database (Inspection Date: 02 May 2022; Report Number: G3-5423/dubrau_roge_20220601) *
French Wholesale Distributor
On 16 June 2022, the competent authority of France (National Agency For The Safety Of Medicine And Health Products) entered a new GPD Non-Compliance Report. This report refers to an inspection performed at a wholesale distributor located in Tierce.
The authority lists the following deficiencies:
- Deficient quality system
- Unsecured and uncontrolled storage conditions (temperature) including for cold chain products
- Failure to implement serialization
- Non-compliance with public service obligations
Source: EudraGMDP Database (Inspection Date: 06 January 2022; Report Number: 2022_NCS_001) *
* To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
30.09.2026European GDP Association Developments May through August 2026
30.09.2026Warehouse Temperature Excursions: What Does the FDA Expect?
30.09.2026Version 4.0 of the Swissmedic Document on Notifications of Changes Published
30.09.2026USA: Court Stops Warehouse Activities Following Persistent Insanitary Warehouse Conditions
30.09.2026GDP Non-Compliance Report: CAPA Measures must not only be Promised but also Implemented
10.09.2026Reminder: Submit your Presentation Proposal for the GDP Forum 2027 by 30 September


